Mixson A J, Hauser P, Tennyson G, Renault J C, Bodenner D L, Weintraub B D
Molecular and Cellular Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
J Clin Invest. 1993 May;91(5):2296-300. doi: 10.1172/JCI116458.
Thyroid hormone resistance (THR) is primarily an autosomal dominant inherited disease characterized by resistance of pituitary and peripheral tissues to the action of thyroid hormone. We investigated whether the heterogeneous phenotypic features that occur not only among kindreds but also within the same kindred might be due to the expression of differing ratios of mutant and normal receptors in tissues. Using an allele-specific primer extension method, we determined the relative expression of normal and mutant mRNAs from the fibroblasts of affected and unaffected members of two kindreds with TRH: A-H and N-N. While two affected members of A-H, as expected, had nearly equal amounts of normal and mutant hTR beta mRNA, two other members had mutant mRNA levels that accounted for at least 70% of the hTR beta mRNA. Phenotypic variability within and between kindreds with generalized resistance to thyroid hormone GRTH may be due to this differential expression of the mutant and wild type mRNA. Furthermore, when several clinical parameters of THR were compared in several affected members from two kindreds with GRTH, we found that two cases in one kindred exhibited a high mutant-to-normal hTR beta ratio and had considerably more bone resistance during their development. In certain kindreds with THR, differing ratios of normal and mutant hTR receptors may be age and growth related and may account for the reported attenuation of phenotypic symptoms with age.
甲状腺激素抵抗(THR)主要是一种常染色体显性遗传病,其特征是垂体和外周组织对甲状腺激素的作用产生抵抗。我们研究了不仅在家族之间而且在同一家族内部出现的异质性表型特征是否可能是由于组织中突变型和正常受体表达比例不同所致。使用等位基因特异性引物延伸法,我们测定了来自两个家族(TRH:A - H和N - N)中受影响和未受影响成员成纤维细胞的正常和突变mRNA的相对表达。正如预期的那样,A - H家族的两名受影响成员的正常和突变hTRβmRNA含量几乎相等,而另外两名成员的突变mRNA水平至少占hTRβmRNA的70%。甲状腺激素全身性抵抗(GRTH)家族内部和之间的表型变异性可能归因于突变型和野生型mRNA的这种差异表达。此外,当比较两个GRTH家族中几名受影响成员的THR的几个临床参数时,我们发现一个家族中的两例表现出较高的突变型与正常型hTRβ比率,并且在其发育过程中具有相当多的骨抵抗。在某些THR家族中,正常和突变hTR受体的不同比例可能与年龄和生长有关,并且可能解释了所报道的表型症状随年龄的减轻。